WASHINGTON, Dec. 29, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new ...
Human babesiosis is an emerging zoonotic disease caused by intraerythrocytic protozoan parasites, of which Babesia microti is the most commonly implicated species in North America and increasingly ...
Further validates continuation of the B-FREE Study to evaluate the efficacy and safety of ARAKODA- (tafenoquine) for treatment of chronic babesiosisData support theory among specialists that Babesia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback